Paul Boomkamp reappointed as director and CFO Erasmus MC
The Supervisory Board has reappointed Dr Paul Boomkamp as member and CFO of the Erasmus MC Executive Board. The reappointment takes effect from 1 November 2024 and is for a period of five years.
It’s a common situation in intensive care: patients who are “fighting the ventilator”. A team from Erasmus MC and the startup Deep Breath is working with AI-driven software to find a solution for this harmful phenomenon.
‘If I wake up and say ‘Ajax,’ the surgery has failed’
Epileptic seizures and a brain hemorrhage caused Tom van Vliet to lose trust in his own body. But after a complex, tense, and successful surgery, he now dares to make plans for his retirement. A procedure he would recommend to anyone. ‘Otherwise, we would still be living in uncertainty.’
ERC Starting Grant for research on organ trafficking and healthy generations
Criminologist Frederike Ambagtsheer and pediatrician Romy Gaillard from Erasmus MC have both been awarded a Starting Grant from the European Research Council (ERC). They will use the €1.5 million grant for research into organ trafficking and the embryonic origins of cardiovascular diseases.
Discovery of new target in aggressive breast cancer opens door for new immunotherapy
Researchers from Erasmus MC have found a novel target for immunotherapy for an aggressive form of breast cancer. They isolated a receptor from white blood cells that recognizes the target and took the first steps towards a clinical treatment. “It was like searching for a needle in a haystack.”
Crucial role of vector control in the fight against visceral leishmaniasis in India
A new study has revealed that indoor residual spraying (IRS) with insecticides has been instrumental in curbing the spread of visceral leishmaniasis in India by significantly reducing the population of sandflies responsible for transmitting the disease.
Joyce is building a village in a petri dish to comprehend diversity
No human being is the same. Everything, from our risk of getting sick to how we respond to treatment, varies from person to person. Professor of population genetics Joyce van Meurs and her team hope to fathom those differences between people with villages of stem cells. ‘I am very excited about this.’
